Loading
Local Infusion
Local Infusion is a tech-enabled ambulatory infusion center network founded in 2022. The company specializes in outpatient infusion therapy for chronic autoimmune and oncology conditions. With a mission to enhance the specialty infusion industry, Local Infusion focuses on providing exceptional, patient-centered care supported by AI-driven technology. This approach has resulted in a 98% patient satisfaction score across its centers. Operating over 20 locations in states such as Maine, New Hampshire, Connecticut, New Jersey, Virginia, and Maryland, Local Infusion has recently expanded into the D.C. area and plans to grow further into suburban Maryland and Northern Virginia. The company administers a wide range of therapies for conditions like multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis, offering over 150 infusible and injectable medications. Local Infusion's proprietary technology streamlines workflows for clinicians and enhances patient access, making it a valuable partner in the healthcare ecosystem.
Funding
Every round, secondary, debt facility or acquisition involving Local Infusion that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$9M